{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:50:39Z","timestamp":1791474639841,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s40263-015-0272-9","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T09:12:44Z","timestamp":1442308364000},"page":"801-809","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study"],"prefix":"10.1007","volume":"29","author":[{"given":"Jerome","family":"Sarris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Camfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia M.","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Dowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deidre J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenifer","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Blair-West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee H.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,15]]},"reference":[{"key":"272_CR1","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (VA): American Psychiatric Association; 2013.","edition":"5"},{"issue":"6","key":"272_CR2","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.conb.2011.04.010","volume":"21","author":"JT Ting","year":"2011","unstructured":"Ting JT, Feng G. Neurobiology of obsessive-compulsive disorder: insights into neural circuitry dysfunction through mouse genetics. Curr Opin Neurobiol. 2011;21(6):842\u20138.","journal-title":"Curr Opin Neurobiol"},{"issue":"4","key":"272_CR3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.biopsych.2012.10.006","volume":"73","author":"BJ Harrison","year":"2013","unstructured":"Harrison BJ, Pujol J, Cardoner N, et al. Brain corticostriatal systems and the major clinical symptom dimensions of obsessive-compulsive disorder. Biol Psychiatry. 2013;73(4):321\u20138.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"272_CR4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biopsych.2008.06.019","volume":"65","author":"JY Rotge","year":"2009","unstructured":"Rotge JY, Guehl D, Dilharreguy B, et al. Meta-analysis of brain volume changes in obsessive-compulsive disorder. Biol Psychiatry. 2009;65(1):75\u201383.","journal-title":"Biol Psychiatry"},{"issue":"7","key":"272_CR5","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.biopsych.2009.10.007","volume":"67","author":"JY Rotge","year":"2010","unstructured":"Rotge JY, Langbour N, Jaafari N, et al. Anatomical alterations and symptom-related functional activity in obsessive-compulsive disorder are correlated in the lateral orbitofrontal cortex. Biol Psychiatry. 2010;67(7):e37\u20138.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"272_CR6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tics.2011.11.003","volume":"16","author":"MR Milad","year":"2012","unstructured":"Milad MR, Rauch SL. Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways. Trends Cogn Sci. 2012;16(1):43\u201351.","journal-title":"Trends Cogn Sci."},{"issue":"6137","key":"272_CR7","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1126\/science.1234733","volume":"340","author":"SE Ahmari","year":"2013","unstructured":"Ahmari SE, Spellman T, Douglass NL, et al. Repeated cortico-striatal stimulation generates persistent OCD-like behavior. Science. 2013;340(6137):1234\u20139.","journal-title":"Science"},{"issue":"3","key":"272_CR8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.pharmthera.2011.09.006","volume":"132","author":"C Pittenger","year":"2011","unstructured":"Pittenger C, Bloch MH, Williams K. Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment. Pharmacol Ther. 2011;132(3):314\u201332.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"272_CR9","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.pbb.2011.10.007","volume":"100","author":"K Wu","year":"2012","unstructured":"Wu K, Hanna GL, Rosenberg DR, et al. The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder. Pharmacol Biochem Behav. 2012;100(4):726\u201335.","journal-title":"Pharmacol Biochem Behav"},{"key":"272_CR10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/YCO.0000000000000017","volume":"27","author":"C Kariuki-Nyuthe","year":"2014","unstructured":"Kariuki-Nyuthe C, Gomez-Mancilla B, Stein D. Obsessive compulsive disorder and the glutamate system. Curr Opin Psychiatry. 2014;27:32\u20137.","journal-title":"Curr Opin Psychiatry"},{"issue":"6","key":"272_CR11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/00048670802050546","volume":"42","author":"M Yucel","year":"2008","unstructured":"Yucel M, Wood SJ, Wellard RM, et al. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder. Aust N Z J Psychiatry. 2008;42(6):467\u201377.","journal-title":"Aust N Z J Psychiatry"},{"issue":"12","key":"272_CR12","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1038\/npp.2009.77","volume":"34","author":"S Bhattacharyya","year":"2009","unstructured":"Bhattacharyya S, Khanna S, Chakrabarty K, et al. Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder. Neuropsychopharmacology. 2009;34(12):2489\u201396.","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"272_CR13","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.npp.1300733","volume":"30","author":"K Chakrabarty","year":"2005","unstructured":"Chakrabarty K, Bhattacharyya S, Christopher R, et al. Glutamatergic dysfunction in OCD. Neuropsychopharmacology. 2005;30(9):1735\u201340.","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"272_CR14","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1369\/jhc.5A6840.2006","volume":"54","author":"J Burdo","year":"2006","unstructured":"Burdo J, Dargusch R, Schubert D. Distribution of the cystine\/glutamate antiporter system xc- in the brain, kidney, and duodenum. J Histochem Cytochem. 2006;54(5):549\u201357.","journal-title":"J Histochem Cytochem"},{"issue":"6","key":"272_CR15","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.pnpbp.2006.03.034","volume":"30","author":"S Ersan","year":"2006","unstructured":"Ersan S, Bakir S, Erdal Ersan E, et al. Examination of free radical metabolism and antioxidant defence system elements in patients with obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(6):1039\u201342.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"272_CR16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pnpbp.2008.10.004","volume":"33","author":"E Ozdemir","year":"2009","unstructured":"Ozdemir E, Cetinkaya S, Ersan S, et al. Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(1):62\u20135.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"272_CR17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000306591","volume":"61","author":"A Behl","year":"2010","unstructured":"Behl A, Swami G, Sircar SS, et al. Relationship of possible stress-related biochemical markers to oxidative\/antioxidative status in obsessive-compulsive disorder. Neuropsychobiology. 2010;61(4):210\u20134.","journal-title":"Neuropsychobiology"},{"issue":"2","key":"272_CR18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pnpbp.2009.01.001","volume":"33","author":"S Chakraborty","year":"2009","unstructured":"Chakraborty S, Singh OP, Dasgupta A, et al. Correlation between lipid peroxidation-induced TBARS level and disease severity in obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(2):363\u20136.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"27","key":"272_CR19","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1523\/JNEUROSCI.1007-05.2005","volume":"25","author":"MM Moran","year":"2005","unstructured":"Moran MM, McFarland K, Melendez RI, et al. Cystine\/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking. J Neurosci. 2005;25(27):6389\u201393.","journal-title":"J Neurosci"},{"issue":"1\u20133","key":"272_CR20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejphar.2010.09.035","volume":"649","author":"KH Choy","year":"2010","unstructured":"Choy KH, Dean O, Berk M, et al. Effects of N-acetyl-cysteine treatment on glutathione depletion and a short-term spatial memory deficit in 2-cyclohexene-1-one-treated rats. Eur J Pharmacol. 2010;649(1\u20133):224\u20138.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"272_CR21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tips.2013.01.001","volume":"34","author":"M Berk","year":"2013","unstructured":"Berk M, Malhi GS, Gray LJ, et al. The promise of N-acetylcysteine in neuropsychiatry. Trends Pharmacol Sci. 2013;34(3):167\u201377.","journal-title":"Trends Pharmacol Sci"},{"key":"272_CR22","doi-asserted-by":"crossref","unstructured":"Deepmala, Slattery J, Kumar N, et al. Clinical trials of N-acetylcysteine in psychiatry and neurology: a systematic review. Neurosci Biobehav Rev. 2015;55:294\u2013321.","DOI":"10.1016\/j.neubiorev.2015.04.015"},{"issue":"4","key":"272_CR23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","volume":"7","author":"K Atkuri","year":"2007","unstructured":"Atkuri K, Mantovani J, Herzenberg L. N-Acetylcysteine a safe antidote for cysteine\/glutathione deficiency. Curr Opin Pharmacol. 2007;7(4):355\u20139.","journal-title":"Curr Opin Pharmacol"},{"issue":"7","key":"272_CR24","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/archgenpsychiatry.2009.60","volume":"66","author":"JE Grant","year":"2009","unstructured":"Grant JE, Odlaug BL, Kim SW. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Arch Gen Psychiatry. 2009;66(7):756\u201363.","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"272_CR25","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.biopsych.2006.11.021","volume":"62","author":"JE Grant","year":"2007","unstructured":"Grant JE, Kim SW, Odlaug BL. N-Acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol Psychiatry. 2007;62(6):652\u20137.","journal-title":"Biol Psychiatry"},{"issue":"3","key":"272_CR26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2174\/1871523011312030003","volume":"12","author":"A Ghanizadeh","year":"2013","unstructured":"Ghanizadeh A, Derakhshan N, Berk M. N-Acetylcysteine versus placebo for treating nail biting, a double blind randomized placebo controlled clinical trial. Antiinflamm Antiallergy Agents Med Chem. 2013;12(3):223\u20138.","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"issue":"6","key":"272_CR27","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/JCP.0b013e318272677d","volume":"32","author":"H Afshar","year":"2012","unstructured":"Afshar H, Roohafza H, Mohammad-Beigi H, et al. N-Acetylcysteine add-on treatment in refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial. J Clin Psychopharmacol. 2012;32(6):797\u2013803.","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"272_CR28","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.biopsych.2008.04.022","volume":"64","author":"M Berk","year":"2008","unstructured":"Berk M, Copolov DL, Dean O, et al. N-Acetyl cysteine for depressive symptoms in bipolar disorder\u2014a double-blind randomized placebo-controlled trial. Biol Psychiatry. 2008;64(6):468\u201375.","journal-title":"Biol Psychiatry"},{"issue":"5","key":"272_CR29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.biopsych.2008.03.004","volume":"64","author":"M Berk","year":"2008","unstructured":"Berk M, Copolov D, Dean O, et al. N-Acetyl cysteine as a glutathione precursor for schizophrenia\u2014a double-blind, randomized, placebo-controlled trial. Biol Psychiatry. 2008;64(5):361\u20138.","journal-title":"Biol Psychiatry"},{"issue":"5","key":"272_CR30","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/art.37893","volume":"65","author":"RJ Garcia","year":"2013","unstructured":"Garcia RJ, Francis L, Dawood M, et al. Attention deficit and hyperactivity disorder scores are elevated and respond to N-acetylcysteine treatment in patients with systemic lupus erythematosus. Arthritis Rheum. 2013;65(5):1313\u20138.","journal-title":"Arthritis Rheum"},{"key":"272_CR31","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","volume":"46","author":"W Goodman","year":"1989","unstructured":"Goodman W. The Yale-Brown obsessive compulsive scale. Arch Gen Psychiatry. 1989;46:1006\u201311.","journal-title":"Arch Gen Psychiatry"},{"key":"272_CR32","unstructured":"CGI: Clinical Global Impressions. In: Guy W, Bonato R, editors. Manual for the ECDEU Assessment Battery. 2nd revised edition. Chevy Chase: National Institute of Mental Health;1970. p. 121\u2013126."},{"issue":"1","key":"272_CR33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M Hamilton","year":"1959","unstructured":"Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50\u20135.","journal-title":"Br J Med Psychol"},{"key":"272_CR34","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382\u20139.","journal-title":"Br J Psychiatry"},{"key":"272_CR35","volume-title":"Manual of the General Health Questionnaire","author":"D Goldberg","year":"1978","unstructured":"Goldberg D. Manual of the General Health Questionnaire. Windsor: NFER Publishing; 1978."},{"issue":"1","key":"272_CR36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/mp.2008.94","volume":"15","author":"AM Ruscio","year":"2010","unstructured":"Ruscio AM, Stein DJ, Chiu WT, et al. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15(1):53\u201363.","journal-title":"Mol Psychiatry"},{"issue":"4","key":"272_CR37","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/npp.2010.226","volume":"36","author":"SL Amen","year":"2011","unstructured":"Amen SL, Piacentine LB, Ahmad ME, et al. Repeated N-acetyl cysteine reduces cocaine seeking in rodents and craving in cocaine-dependent humans. Neuropsychopharmacology. 2011;36(4):871\u20138.","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"272_CR38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.9758\/cpn.2015.13.1.12","volume":"13","author":"G Oliver","year":"2015","unstructured":"Oliver G, Dean O, Camfield D, et al. N-Acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic review. Clin Psychopharmacol Neurosci. 2015;13(1):12\u201324.","journal-title":"Clin Psychopharmacol Neurosci."}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-015-0272-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-015-0272-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-015-0272-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:41:25Z","timestamp":1559490085000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-015-0272-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["272"],"URL":"https:\/\/doi.org\/10.1007\/s40263-015-0272-9","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725798500.793522021","asserted-by":"object"}]},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}